D.E. Shaw & Co’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $927K | Buy |
+401,509
| New | +$927K | ﹤0.01% | 2267 |
|
|
2022
Q4 | – | Sell |
-107,274
| Closed | -$207K | – | 3804 |
|
|
2022
Q3 | $207K | Sell |
107,274
-27,311
| -20% | -$52.7K | ﹤0.01% | 3208 |
|
|
2022
Q2 | $501K | Buy |
134,585
+59,851
| +80% | +$223K | ﹤0.01% | 3037 |
|
|
2022
Q1 | $487K | Buy |
+74,734
| New | +$487K | ﹤0.01% | 3219 |
|
|
2021
Q3 | – | Sell |
-11,448
| Closed | -$243K | – | 3859 |
|
|
2021
Q2 | $243K | Buy |
+11,448
| New | +$243K | ﹤0.01% | 3178 |
|